75K LifeStance (NASDAQ: LFST) shares sold by director-linked entities

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

LifeStance Health Group director Robert Bessler reported open-market sales of LifeStance Health Group, Inc. common stock through entities associated with him. Shama LLC and Vitthal LLC each sold 37,500 shares at a weighted average price of $8.55 per share, in transactions ranging from $8.40 to $8.89. After these sales, Shama LLC held 1,353,746 shares and Vitthal LLC held 1,236,948 shares. Bessler also reported 57,619 shares held directly and 36,363 shares held by Alpine Glow Capital. Footnotes state that he disclaims beneficial ownership of these indirect holdings except to the extent of his pecuniary interest.

Insider Trade Summary 10b5-1

Net Seller: 75,000 shares ($641,250)

Net Sell 4 txns

Insider Bessler Robert

Role null

Sold 75,000 shs ($641K)

Type	Security	Shares	Price	Value
Sale	Common Stock	37,500	$8.55	$321K
Sale	Common Stock	37,500	$8.55	$321K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,236,948 shares (Indirect, Vitthal LLC); Common Stock — 57,619 shares (Direct, null)

Footnotes (1)

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.40 to $8.89 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

Key Figures

Total shares sold: 75,000 shares Weighted average sale price: $8.55 per share Price range of trades: $8.40–$8.89 per share +4 more

7 metrics

Total shares sold 75,000 shares Two open-market sales of 37,500 shares each on May 7, 2026

Weighted average sale price $8.55 per share Common stock sales in multiple trades from $8.40 to $8.89

Price range of trades $8.40–$8.89 per share Range for the multiple transactions comprising the reported sales

Shama LLC post-sale holdings 1,353,746 shares Common stock held indirectly after selling 37,500 shares

Vitthal LLC post-sale holdings 1,236,948 shares Common stock held indirectly after selling 37,500 shares

Direct holdings 57,619 shares Common stock reported as held directly by Robert Bessler

Alpine Glow Capital holdings 36,363 shares Common stock held of record by Alpine Glow Capital

Key Terms

weighted average price, beneficial ownership, pecuniary interest, Section 16 of the Exchange Act, +1 more

5 terms

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"

Section 16 of the Exchange Act regulatory

"for purposes of Section 16 of the Exchange Act or for any other purpose"

indirect ownership financial

"ownership_type: "indirect" with nature_of_ownership entries such as Shama LLC and Vitthal LLC"

Form 4 Insider Transactions: What Each Field Means →

05/11/2026 - 05:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bessler Robert

(Last)

(First)

(Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 6000

(Street)

SCOTTSDALE

ARIZONA

85251

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/07/2026		S		37,500	D	$8.55⁽¹⁾	1,236,948	I	Vitthal LLC⁽²⁾
Common Stock	05/07/2026		S		37,500	D	$8.55⁽¹⁾	1,353,746	I	Shama LLC⁽³⁾
Common Stock								57,619	D
Common Stock								36,363	I	See Footnote⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.40 to $8.89 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose.

3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

4. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

	By: /s/ Ryan Pardo, Attorney-in-Fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did LifeStance Health (LFST) report for Robert Bessler?

LifeStance Health reported that entities associated with director Robert Bessler sold 75,000 shares of common stock. The sales were made by Shama LLC and Vitthal LLC, which continue to hold over 1.3 million and 1.2 million shares, respectively, after the transactions.

How many LifeStance Health (LFST) shares were sold and at what price?

A total of 75,000 LifeStance Health shares were sold, split into two blocks of 37,500 shares. The weighted average sale price was $8.55 per share, with individual trades executed between $8.40 and $8.89 according to the disclosure.

How many LifeStance Health (LFST) shares do the selling entities hold after the Form 4?

After the reported sales, Shama LLC holds 1,353,746 LifeStance Health shares and Vitthal LLC holds 1,236,948 shares. Additional reported holdings include 57,619 shares directly and 36,363 shares held by Alpine Glow Capital, as reflected in the filing.

Does Robert Bessler claim full beneficial ownership of the LFST shares reported?

The filing states that Robert Bessler disclaims beneficial ownership of certain reported securities except to the extent of his pecuniary interest. This applies to indirect holdings through entities such as Shama LLC, Vitthal LLC, and Alpine Glow Capital, as specified in the footnotes.

Were the LFST insider sales made in the open market?

Yes, the transactions are coded as open-market or private sales of common stock. The Form 4 notes that the 37,500-share blocks were sold at a weighted average price, across individual trades executed within a stated price range between $8.40 and $8.89.

What indirect ownership structures are involved in this LFST Form 4 filing?

The filing identifies Shama LLC, Vitthal LLC, and Alpine Glow Capital as entities holding LifeStance Health shares associated with Robert Bessler. Footnotes explain that shares are held of record by these entities, with Bessler disclaiming beneficial ownership except for his pecuniary interest.